ZVRA Zevra Therapeutics, Inc.
$10.06▲ +5.51%
Healthcare
Other
After hours
$10.06▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.09M
Avg Volume (10D) 678.9K
Key Metrics & Fundamentals
Market Cap
$597.10M
P/E Ratio
10.9
Div Yield
0.00%
52W Range
8.01 - 15.04
% vs 50 MA
-10.78%
% vs 200 MA
-6.24%
RSI-14
42.3
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.93
Free Cash Flow
$16.82M
Gross Rev
$39.66M
Gross Profit
$38.14M
EBITDA
$19.71M
COGS
$1.53M
Operating Exp
$21.36M
Operating Income
$16.78M
EBIT
$16.78M
Pretax Income
$12.79M
Net Income
$8.75M
EPS (Diluted)
0.14
Price & Volume History
Loading chart…
Recent News
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
GlobeNewswire · Oct 20, 2026 7:30 AM ET
Zevra Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 7:30 AM ET
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
GlobeNewswire · Aug 25, 2026 7:30 AM ET
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 21, 2026 4:30 PM ET
Zevra Therapeutics Insider Sold Shares Worth $474,774, According to a Recent SEC Filing
MT Newswires · Aug 17, 2026 4:38 PM ET
What Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review?
Simply Wall St. · Aug 7, 2026 1:12 AM ET
Zevra Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 4:04 AM ET
Zevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights: Revenue Surges 53% as ...
GuruFocus.com · Aug 6, 2026 1:08 AM ET
Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates
Zacks · Aug 5, 2026 8:35 PM ET
Zevra Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 5:15 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ZVRA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.